Embr Labs Celebrated as Best OTC Product at Major Expo
Embr Labs is excited to announce that it has been named the Best OTC Healthcare Product at a significant industry expo where retailers and suppliers gather. This award underscores the company’s dedication to delivering innovative health solutions, especially for women navigating menopause. The Embr Wave®, a groundbreaking wrist-worn device, utilizes temperature management to ease hot flashes, improve sleep quality, and lower stress levels.
The Embr Wave® and Its Benefits
Designed with the needs of 1.1 billion women experiencing menopause in mind, the Embr Wave® offers a natural alternative to conventional medications. Its appeal isn't limited to its target audience; it's also gaining traction among men and women of all ages who are seeking relief from temperature discomfort and stress. Thanks to its unique technology, users can feel either cooling or warming sensations that can help shift their mood and physical state.
A Sign of True Innovation
Jesse Hester, VP of Commercial Sales at Embr Labs, shared the team’s enthusiasm about the award, stating, "We were thrilled to be recognized by retail buyers as the best OTC product at the show. This award opens doors for the Embr Wave to reach a wider audience through major retailers in the U.S., marking a key step in our mission to make our products accessible to those who need them." This recognition not only highlights the innovative nature of the product but also helps pave the way for wider distribution.
Collaborations Boost Visibility
In a nod to teamwork, Hester pointed out that Embr Labs, alongside other health tech pioneers, successfully showcased their innovations at the expo. By collaborating with notable brands like Audien Hearing, which makes hearing aids affordable, Nufabrx, specializing in medication-infused compression sleeves, and Kihealth, focusing on diagnostic kits, Embr Labs demonstrated the power of partnership in enhancing visibility in the market.
Recent Achievements and Future Plans
The accolade from the Total Store Expo comes after a series of important milestones for Embr Labs, including a strategic push into international markets and being recognized as a semi-finalist for the Best in Class Women's Healthcare Product by the Digital Health Hub Foundation. These accomplishments reflect the company's relentless drive for innovation in the health technology space.
About Embr Labs
Founded at MIT, Embr Labs is at the cutting edge of health technology, transforming how people manage health issues through temperature control. Supported by notable partners like Bose Ventures and DigiTx Partners, Embr Labs has earned multiple accolades for its pioneering efforts. It has received the AARP Innovation in Aging Award and has been included in CB Insights' Digital Health 150 list. Through constant innovation, Embr Labs has positioned itself as a reliable solution for addressing menopause and other temperature-related health challenges.
Contact Information
For media inquiries, please reach out to: Sam Shames
Frequently Asked Questions
What is the Embr Wave®?
The Embr Wave® is a wearable device that employs temperature control to help users manage symptoms related to menopause, enhance sleep quality, and reduce stress.
Why was Embr Labs selected as the best OTC product?
Embr Labs received recognition from retail buyers at a major expo for its innovative approach and effectiveness in addressing health issues related to menopause and overall thermal comfort.
How does the Embr Wave® work?
The device delivers warming or cooling sensations to your wrist, aiding the brain in regulating body temperature and offering relief from discomfort.
Who can benefit from using the Embr Wave®?
While primarily aimed at women undergoing menopause, the Embr Wave® can also provide benefits to individuals of all ages who seek thermal comfort and stress relief.
What awards has Embr Labs received?
Embr Labs has earned various awards, including the AARP Innovation in Aging Award and recognition as one of the Digital Health 150 companies by CB Insights.
